RMED

Ra Medical Systems, Inc. (RMED) | Rumor.io

Ra Medical Systems

RMED

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about RMED?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 7

The CEO of Ra Medical Systems, Inc. has invested over $25 million at an average price of $3.20, demonstrating confidence in the company's prospects.
Ra Medical Systems has announced a milestone achievement in its Electrophysiology Division, with its VIVO System being used in over 1,000 procedures.
The stock has seen a significant price increase, with a 25% rise to $0.79, due to the announcement and the company's low float and high relative volume.

Generated by AI

Sentiment

Of the messages about RMED that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Bullish· Dec 9

$RMED has already seen a 230% gain from its alert price, reaching $6.30.
The stock is expected to continue its upward trend, potentially reaching over $10.
A successful merger via warrants could drive the price even higher, with some analysts predicting a move above $8 and then $10.

Bearish· Jan 10

The company's merger with Catheter Precision may have been poorly timed and executed, leading to a negative market reaction.
The company's management team is accused of diluting shareholders by dumping shares, which has contributed to the stock's decline.
The stock's low float and heavy shorting have exacerbated the decline, making it difficult for the stock to recover despite the positive news of the merger.

Generated by AI

Topics

Of the messages about RMED that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Announcements· Dec 5

Ra Medical Systems' stock price is predicted to have a sharp negative trend in the short term due to existing long-term fundamentals.
There is no specific announcement about Ra Medical Systems in this post, but it mentions the company's stock price in the context of the US economy adding 263,000 jobs.
There is no specific announcement about Ra Medical Systems in this post, but it mentions the company's stock price in the context of the Dow Jones tumbling 300 points.

Technical Analysis· Dec 2

The stock $RMED has shown a strong performance with 5 consecutive green days, resulting in a profit of $2,000.
The 200 EMA on the 5-minute chart has been effective in identifying the bottom of the stock, making it a reliable indicator for traders.
The stock has formed a potential flag pattern, with a possible move back to $5.00 or $5.11, and a VWAP crossover indicating a strong uptrend.

Generated by AI

Community

Of the messages about RMED, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	100%
Newcomers	—	—	—	0%

Regulars· Jan 23

Ra Medical Systems, Inc. (RMED) announces presentation of clinical data at the European Heart Rhythm Association Congress, with four abstracts accepted for presentation at the leading electrophysiology conference.
The clinical data supports the use of Catheter Precision's VIVO technology, a key aspect of RMED's business.
RMED's presentation at the European Heart Rhythm Association Congress is a significant development for the company, which has a low float and is known for its news-sensitive stock price.

Newcomers· Jul 3

RMED's Electrophysiology Division is expanding international distribution, with the company announcing a strong effort to expand its distribution outside of the US.
The company has filed for the CE Mark on LockeT, a new device, and is seeing exciting prospects with hospitals in the US already requesting trials.
RMED's shares are trading higher after the company's announcement, with the stock price spiking 17.39% and the company's low float being cited as a factor.

Generated by AI

Also Discussed

Investors talking about RMED also mention

#	Name	Attention
1	Digital Brands Group, Inc. Common StockDBGI	0%0
2	CYRN - Cyren Ltd.	——
3	XELA - Exela Technologies, Inc.	——
4	SEAC - SeaChange International, Inc.	——
5	BOXD - Boxed, Inc.	——
6	TCDA - Tricida, Inc.	——
7	GHSI - Guardion Health Sciences, Inc.	——
8	NOVN - Novan, Inc.	——
9	SNMP - Evolve Transition Infrastructure LP	——
10	HLBZ - Helbiz, Inc.	——